[1]闫福堂,苏宝凤,詹颉,等.血清可溶性ST2与血BNP在心力衰竭患者中的相关性研究[J].现代检验医学杂志,2015,30(06):78-79.[doi:10.3969/j.issn.1671-7414.2015.06.022]
　YAN Fu-tang,SU Bao-feng,ZHAN Jie,et al.Correlation between Serum Soluble ST2 and BNP in Patients with Heart Failure[J].Journal of Modern Laboratory Medicine,2015,30(06):78-79.[doi:10.3969/j.issn.1671-7414.2015.06.022]
点击复制

血清可溶性ST2与血BNP在心力衰竭患者中的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年06期
页码:
78-79
栏目:
论著
出版日期:
2015-12-30

文章信息/Info

Title:
Correlation between Serum Soluble ST2 and BNP in Patients with Heart Failure
作者:
闫福堂; 苏宝凤; 詹颉; 张华; 袁军; 党小军; 郑霄; 奚逢瑜
陕西省人民医院检验科，西安710068
Author(s):
YAN Fu-tang; SU Bao-feng; ZHAN Jie; ZHANG Hua; YUAN Jun; DANG Xiao-jun;  ZHENG Xiao; XI Feng-yu
Deparment of Clinical Laboratory， Shaanxi Provincial People’s Hospital，Xi’an 710068，China
关键词:
心力衰竭; 可溶性ST2; B型脑钠肽; 相关性
分类号:
R541.6；R446.112
DOI:
10.3969/j.issn.1671-7414.2015.06.022
文献标志码:
A
摘要:
目的观察心力衰竭患者血清可溶性ST2(sST2)水平变化，分析其与B型脑钠肽(BNP)的相关性，探讨sST2在心力衰竭诊断中的应用价值。方法选取2013年10月～2015年4月于陕西省人民医院已确诊的心力衰竭住院患者216例，按纽约心脏协会(NYHA)心功能分级标准分为心功能Ⅰ级组62例、心功能II级组58例、心功能III级组54例和心功能IV级组42例；并收集胸部X线片、心脏彩超和心功能正常的80例作为对照组。用ELISA法测定血清sST2浓度和用电化学免疫发光法测定血浆BNP水平；采用SPSS18．0统计软件包对数据进行统计学处理。结果心功能I～IV级组血清sST2均显著高于正常对照组，差异均有统计学意义(P＜0.05或P＜0.001)；心功能I～IV级组之间，心功能II级组高于心功能I级组(P＜0.05)，心功能III，IV级组均显著高于心功能I，II级组(P＜0.001)，而心功能IV级组虽然与心功能III级组有差异，但无统计学意义(P＞0.05)。而心功能I～IV级组血浆BNP水平均显著高于正常对照组(P＜0.001)，并且随着心功能分级递增而逐渐升高，四组之间比较差异均有统计学意义(均P<0.001)。 相关性分析，sST2与BNP呈正相关(r=0.453，P<0.01)；根据心力衰竭诊断的ROC曲线下面积：sST2为0.812，灵敏度为83%，特异度为71%；BNP为0.913，灵敏度为88%，特异度为79%；两者联合诊断心力衰竭价值升高，ROC曲线下面积为0.941，灵敏度为92%，特异度为83%。结论血清sST2与血浆BNP呈正相关，可作为心力衰竭诊断的新的生化指标。sST2联合BNP检测可提高对心力衰竭的诊断价值。
Abstract:
ObjectiveTo observe serum soluble ST2 (sST2) level of patients with heart failure，analyze its correlation with type B brain natriuretic peptide (BNP)，and explore the application value of sST2 in diagnosis of heart failure．MethodsSelected 216 cases of hospitalized patients with heart failure in Shaanxi Provincial People’s Hospital from April 2013 to October 2015．According to the classification standard of New York Heart Association (NYHA) for cardiac function，they were divided into cardiac function Ⅰ grade group (62 cases)，Ⅱ (58 cases)，Ⅲ　(54 cases) and Ⅳ (42 cases)，and to collect chest X-ray，echocardiography and cardiac function in normal 80 cases as control group．The serum sST2 concentrations were determined by ELISA，the plasma BNP levels were determined by electrochemical immunoassay，and the data were statistically analyzed by SPSSl8.0 statistics software．ResultsSerum sST2 of cardiac function I to IV group were significantly higher than that in the normal control group(P<0.05 or P<0.001)．Between the cardiac function Ⅰ～ Ⅳ group，serum sST2 of Ⅱ group was higher than that of Ⅰ group (P<0.05)，serum sst2 of Ⅲ and Ⅳ group were significantly higher than those of Ⅰ and Ⅱ group (P<0.001)．Although cardiac function Ⅲ grade group was different from the functional Ⅳ grade，but no statistical significance (P>0.05)．Cardiac function Ⅰ to Ⅳ group，the plasma BNP levels were significantly higher than those of normal control group (P<0.001)，and with the cardiac function grading increasing，the plasma BNP levels gradually increased．Compared the four groups，differences were statistically significant　(P<0.001)．Correlation analysis，sST2 and BNP were positively correlated (r= 0.453，P<0.01)．According to the area under the ROC curve for the diagnosis of heart failure：sST2 was 0.812，sensitivity was 83% and specificity was 71%；BNP was 0.913，sensitivity was 88%，and specificity was 79%．Both combined diagnosis，the value of heart failure increased，area of under the ROC curve was 0.941，sensitivity was 92% and specificity was 83%．ConclusionSerum sST2 and BNP were positively correlated，and they could be used as the new biochemical index for the diagnosis of heart failure．combined detection of sST2 and BNP can improve the diagnostic value of heart failure．

参考文献/References:

［1］中华医学会心血管病学分会，中华心血管病杂志编辑委员会．中国心力衰竭诊断和治疗指南2014［J］．中华心血管病杂志，2014，42(2)：98-122．
[2]Ky B，French B，McCloskey K，et al．High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure［J］．Circ Heart Fail，2011，4(2)：180-187．
[3]邸玉青，彭道泉．可溶性ST2对慢性心力衰竭患者的诊断价值探讨［J］．中国心血管杂志，2013，18(5)：334-338． Di YQ,Peng DQ.Role of soluble ST2 in the diagnosis of heart failure ［J］．Chinese Journal of Cardiovascular Medicine，2013，18(5)：334-338．
[4]Bayes-Genis A，Pascual-Figal D，Januzzi JL，et al．So-luble ST2 monitoring providea additional risk stratification for outpatients with decompensated heart faiure［J］．Rev Eap Cardiol，2010，63(10)：1171-1178．
[5]罗义红，茅斌，张鑫，等．B型利钠肽在心力衰竭治疗中的临床意义［J］．医学临床研究，2012，29(9)：1807-1808．
[6]袁伟，顾宇英，张代富．心力衰竭患者血清可溶性ST2水平的测定及其诊断价值［J］．第二军医大学学报，2012，33(2)：175-178． Yuan W,Gu YY,Zhang DF.Measurement of serum soluble ST2 in patients with heart failure and its diagnostic value［J］．Academic Journal of Second Military Medical Univeraity，2012，33(2)：175-178．
[7]Broch K，Ueland T，Nymo SH，et al．Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology［J］．Eur J Heart Fail，2012，14(3)：268-277．
[8]Gaggin HK，Motiwala S，Bhardwaj A，et al．Soluble concentrations of the interleukin receptor family member ST2 and β-blocker therapy in chronic heart failure［J］．Circ Heart Fail，2013，6(6)：1206-1213．

相似文献/References:

[1]丁春梅,胡志德,刘晓斐,等.MR-proANP：一种新型心力衰竭诊断标志物[J].现代检验医学杂志,2015,30(05):99.[doi:10.3969/j.issn.1671-7414.2015.05.0030]
　DING Chun-mei,HU Zhi-de,LIU Xiao-fei,et al.MR-proANP：A Novel Diagnostic Marker for Heart Failure[J].Journal of Modern Laboratory Medicine,2015,30(06):99.[doi:10.3969/j.issn.1671-7414.2015.05.0030]
[2]王 璐,李维娟,杨 靖.血清NT-proBNP和Cys-C水平联合检测在心力衰竭诊断与分型中的应用[J].现代检验医学杂志,2018,33(06):91.[doi:10.3969/j.issn.1671-7414.2018.06.024]
　WANG Lu,LI Wei-juan,YANG Jing.Application of Combined Detection of Serum NT-proBNP and Cys-C Levels in Diagnosis and Typing of Heart Failure[J].Journal of Modern Laboratory Medicine,2018,33(06):91.[doi:10.3969/j.issn.1671-7414.2018.06.024]
[3]屈慧,李娅,黄瑶楠,等.心力衰竭患者外周血RDW 和NT-pro-BNP 联合检测对临床诊断及分级的相关性研究[J].现代检验医学杂志,2020,35(05):65.[doi:10.3969/j.issn.1671-7414.2020.05.017]
　QU Hui,LI Ya,HUANG Yao-nan,et al.Correlation Study on the Combined Detection of RDW and NT-Pro-BNP in Patients with Heart Failure to Clinical Diagnosis and Grading[J].Journal of Modern Laboratory Medicine,2020,35(06):65.[doi:10.3969/j.issn.1671-7414.2020.05.017]
[4]胡小燕,郑　晓,嵇华夏,等.血清 PCT 与 BNP 水平联合检测对慢性阻塞性肺疾病急性加重期并发心力衰竭的临床诊断价值[J].现代检验医学杂志,2021,36(03):128.[doi:10.3969/j.issn.1671-7414.2021.03.029]
　HU Xiao-yan,ZHENG Xiao,JI Hua-xia,et al.Clinical Diagnostic Value of Combined Detection of Serum PCT and BNPLevels in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated with Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(06):128.[doi:10.3969/j.issn.1671-7414.2021.03.029]
[5]李志强,吴正霞,陈　凯,等.心力衰竭患者并发甲型流感的临床和实验室特征分析[J].现代检验医学杂志,2021,36(03):137.[doi:10.3969/j.issn.1671-7414.2021.03.031]
　LI Zhi-qianga,WU Zheng-xiaa,CHEN Kaia,et al.Analysis on the Clinical and Laboratory Characteristics of Heart FailurePatients with Influenza A[J].Journal of Modern Laboratory Medicine,2021,36(06):137.[doi:10.3969/j.issn.1671-7414.2021.03.031]
[6]杨　英,吴　翔,张文华,等.川芎嗪通过调控组蛋白乙酰化修饰上调SERCA2a对心力衰竭小鼠模型的防治机制研究[J].现代检验医学杂志,2021,36(06):34.[doi:10.3969/j.issn.1671-7414.2021.06.007]
　YANG Ying,WU Xiang,ZHANG Wen-hua,et al.Research on Prevention and Control Mechanism of the Ligustrazine Up Regulates SERCA2a by Regulating Histone Acetylation in A Mouse Model of Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(06):34.[doi:10.3969/j.issn.1671-7414.2021.06.007]
[7]温小英,乔印玲,邓桂林.输卵管妊娠患者血清IL-33 和sST2 表达水平与输卵管妊娠期待治疗疗效的相关性研究[J].现代检验医学杂志,2022,37(06):129.[doi:10.3969/j.issn.1671-7414.2022.06.024]
　WEN Xiao-ying,QIAO Yin-ling,DENG Gui-lin.Correlation between the Expression Levels of Serum IL-33 and sST2 in Patients with Tubal Pregnancy and the Efficacy of Expectant Treatment for Tubal Pregnancy[J].Journal of Modern Laboratory Medicine,2022,37(06):129.[doi:10.3969/j.issn.1671-7414.2022.06.024]
[8]李丽霞,李 娜.血清MAO 和IL-6 水平诊断慢性肾衰竭并发心力衰竭的价值及与心功能分级的关系[J].现代检验医学杂志,2023,38(01):147.[doi:10.3969/j.issn.1671-7414.2023.01.027]
　LI Li-xia,LI Na.Value of Serum MAO and IL-6 Levels in the Diagnosis of Chronic Renal Failure Complicated with Heart Failure and Their Relationship with Cardiac Function Grading[J].Journal of Modern Laboratory Medicine,2023,38(06):147.[doi:10.3969/j.issn.1671-7414.2023.01.027]

备注/Memo

备注/Memo:
作者简介：闫福堂(1962-)，男，大学本科，主任检验技师，擅长临床实验室质量控制和管理，研究方向：临床生物化学和临床免疫学方法学及其相关性能研究。
更新日期/Last Update: 1900-01-01